China Cardiovascular Devices Market Outlook to 2020 · China Cardiovascular Devices Market Outlook to 2020 GDMEMC0039DB / Published May 2014 ... 4 Cardiac Assist Devices Market, China

China Cardiovascular Devices Market Outlook to 2020 GDMEMC0039DB / Published May 2014

© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form

Page 1

China Cardiovascular Devices Market

Outlook to 2020

Reference Code: GDMEMC0039DB

Publication Date: May 2014



Page 2

1 Table of Contents

1 Table of Contents .................................................................................................................................................... 2

1.1 List of Tables .................................................................................................................................................... 8

1.2 List of Figures ................................................................................................................................................. 10

2 Introduction ............................................................................................................................................................ 13

2.1 What Is This Report About? ........................................................................................................................... 13

2.2 Cardiovascular Devices Market Segmentation .............................................................................................. 13

2.3 Definitions of Markets Covered in the Report ................................................................................................ 16

3 Cardiovascular Devices Market, China ............................................................................................................... 32

3.1 Cardiovascular Devices Market, China, Revenue ($m), 2005-2020 .............................................................. 32

3.2 Cardiovascular Devices Market, China, Revenue Mix ($m), 2012 ................................................................ 34

3.3 Cardiovascular Devices Market, China, Category Contribution by Revenue ($m), 2012 .............................. 35

3.4 Cardiovascular Devices Market, China, Category Comparison by Revenue ($m), 2005-2020 .................... 37



3.7 Cardiovascular Devices Market, China, Volume (Units), 2005-2020 ............................................................. 43



3.10 Cardiovascular Devices Market, China, Company Share by Revenue ($m), 2011-2012 .............................. 49

4 Cardiac Assist Devices Market, China ................................................................................................................ 51

4.1 Cardiac Assist Devices Market, China, Revenue Mix ($m), 2012 ................................................................. 51

4.2 Cardiac Assist Devices Market, China, Segment Contribution (%), 2012 ..................................................... 52

4.3 Cardiac Assist Devices Market, China, Revenue ($m), by Segment, 2005-2012 ......................................... 53

4.4 Cardiac Assist Devices Market, China, Revenue ($m) by Segment, 2012-2020 .......................................... 55

4.5 Cardiac Assist Devices Market, China, Volume (Units) by Segment, 2005-2012 ......................................... 57

4.6 Cardiac Assist Devices Market, China, Volume (Units) by Segment, 2012-2020 ......................................... 59

4.7 Cardiac Assist Devices Market, China, Distribution Share by Revenue ($m), 2011-2012 ............................ 61

4.8 Cardiac Assist Devices Market, China, Company Share by Revenue ($m), 2011-2012 ............................... 62

5 Cardiac Rhythm Management Market, China ..................................................................................................... 64

5.1 Cardiac Rhythm Management Market, China, Revenue Mix ($m), 2012 ...................................................... 64

5.2 Cardiac Rhythm Management Market, China, Segment Contribution (%), 2012 .......................................... 65

5.3 Cardiac Rhythm Management Market, China, Revenue ($m), by Segment, 2005-2012 .............................. 66

5.4 Cardiac Rhythm Management Market, China, Revenue ($m) by Segment, 2012-2020 ............................... 68

5.5 Cardiac Rhythm Management Market, China, Volume (Units) by Segment, 2005-2012 .............................. 70

5.6 Cardiac Rhythm Management Market, China, Volume (Units) by Segment, 2012-2020 .............................. 72

5.7 Cardiac Rhythm Management Market, China, Distribution Share, Revenue ($m), 2011-2012 ..................... 74

5.8 Cardiac Rhythm Management Market, China, Company Share by Revenue ($m), 2011-2012 ................... 75

6 Cardiovascular Monitoring and Diagnostic Devices Market, China ................................................................. 77

6.1 Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m), 2005-2012 ................... 77

6.2 Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m), 2012-2020 ................... 79



Page 3

6.3 Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), 2005-2012 .................. 81

6.4 Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), 2012-2020 .................. 82

6.5 Cardiovascular Monitoring and Diagnostic Devices Market, China, Distribution Share, Revenue ($m), 2011-2012 83

6.6 Cardiovascular Monitoring and Diagnostic Devices Market, China, Company Share by Revenue ($m), 2011-2012 ................................................................................................................................................................... 84

7 Cardiovascular Prosthetic Devices Market, China ............................................................................................. 86

7.1 Cardiovascular Prosthetic Devices Market, China, Revenue Mix ($m), 2012 ............................................... 86

7.2 Cardiovascular Prosthetic Devices Market, China, Segment Contribution (%), 2012 ................................... 87

7.3 Cardiovascular Prosthetic Devices Market, China, Revenue ($m), by Segment, 2005-2012 ....................... 88

7.4 Cardiovascular Prosthetic Devices Market, China, Revenue ($m) by Segment, 2012-2020 ........................ 90

7.5 Cardiovascular Prosthetic Devices Market, China, Volume (Units) by Segment, 2005-2012 ....................... 92

7.6 Cardiovascular Prosthetic Devices Market, China, Volume (Units) by Segment, 2012-2020 ....................... 94

7.7 Cardiovascular Prosthetic Devices Market, China, Distribution Share, Revenue ($m), 2011-2012 .............. 96

7.8 Cardiovascular Prosthetic Devices Market, China, Company Share by Revenue ($m), 2011-2012 ............ 97

8 Cardiovascular Surgery Market, China ............................................................................................................... 99

8.1 Cardiovascular Surgery Market, China, Revenue Mix ($m), 2012 ................................................................ 99

8.2 Cardiovascular Surgery Market, China, Segment Contribution (%), 2012 .................................................. 100

8.3 Cardiovascular Surgery Market, China, Revenue ($m), by Segment, 2005-2012 ...................................... 101

8.4 Cardiovascular Surgery Market, China, Revenue ($m) by Segment, 2012-2020 ....................................... 103

8.5 Cardiovascular Surgery Market, China, Volume (Units) by Segment, 2005-2012 ...................................... 105

8.6 Cardiovascular Surgery Market, China, Volume (Units) by Segment, 2012-2020 ...................................... 107

8.7 Cardiovascular Surgery Market, China, Distribution Share, Revenue ($m), 2011-2012 ............................. 109

8.8 Cardiovascular Surgery Market, China, Company Share by Revenue ($m), 2011-2012 ............................ 110

9 Electrophysiology Market, China ....................................................................................................................... 112

9.1 Electrophysiology Market, China, Revenue Mix ($m), 2012 ........................................................................ 112

9.2 Electrophysiology Market, China, Segment Contribution (%), 2012 ............................................................ 113

9.3 Electrophysiology Market, China, Revenue ($m), by Segment, 2005-2012 ................................................ 114

9.4 Electrophysiology Market, China, Revenue ($m) by Segment, 2012-2020 ................................................. 116

9.5 Electrophysiology Market, China, Volume (Units) by Segment, 2005-2012 ................................................ 118

9.6 Electrophysiology Market, China, Volume (Units) by Segment, 2012-2020 ................................................ 120

9.7 Electrophysiology Market, China, Distribution Share, Revenue ($m), 2011-2012 ...................................... 122

9.8 Electrophysiology Market, China, Company Share by Revenue ($m), 2011-2012 ..................................... 123

10 External Defibrillators Market, China ............................................................................................................. 125

10.1 External Defibrillators Market, China, Revenue ($m), 2005-2012 ............................................................... 125

10.2 External Defibrillators Market, China, Revenue ($m), 2012-2020 ............................................................... 126

10.3 External Defibrillators Market, China, Volume (Units), 2005-2012 .............................................................. 127

10.4 External Defibrillators Market, China, Volume (Units), 2012-2020 .............................................................. 128

10.5 External Defibrillators Market, China, Distribution Share, Revenue ($m), 2011-2012 ................................ 129

10.6 External Defibrillators Market, China, Company Share by Revenue ($m), 2011-2012 ............................... 130

11 Interventional Cardiology Market, China ....................................................................................................... 132



Page 4

11.1 Interventional Cardiology Market, China, Revenue Mix ($m), 2012 ............................................................ 132

11.2 Interventional Cardiology Market, China, Segment Contribution (%), 2012 ................................................ 133

11.3 Interventional Cardiology Market, China, Revenue ($m), by Segment, 2005-2012 .................................... 135

11.4 Interventional Cardiology Market, China, Revenue ($m) by Segment, 2012-2020 ..................................... 137

11.5 Interventional Cardiology Market, China, Volume (Units) by Segment, 2005-2012 .................................... 139

11.6 Interventional Cardiology Market, China, Volume (Units) by Segment, 2012-2020 .................................... 141

11.7 Interventional Cardiology Market, China, Distribution Share, Revenue ($m), 2011-2012 ........................... 143

11.8 Interventional Cardiology Market, China, Company Share by Revenue ($m), 2011-2012 .......................... 144

12 Peripheral Vascular Devices Market, China .................................................................................................. 146

12.1 Peripheral Vascular Devices Market, China, Revenue Mix ($m), 2012 ....................................................... 146

12.2 Peripheral Vascular Devices Market, China, Segment Contribution (%), 2012 ........................................... 147

12.3 Peripheral Vascular Devices Market, China, Revenue ($m), by Segment, 2005-2012 ............................... 149

12.4 Peripheral Vascular Devices Market, China, Revenue ($m) by Segment, 2012-2020 ................................ 151

12.5 Peripheral Vascular Devices Market, China, Volume (Units) by Segment, 2005-2012 ............................... 153

12.6 Peripheral Vascular Devices Market, China, Volume (Units) by Segment, 2012-2020 ............................... 155

12.7 Peripheral Vascular Devices Market, China, Distribution Share, Revenue ($m), 2011-2012 ..................... 157

12.8 Peripheral Vascular Devices Market, China, Company Share by Revenue ($m), 2011-2012 .................... 158

13 Prosthetic Heart Valves Market, China .......................................................................................................... 160

13.1 Prosthetic Heart Valves Market, China, Revenue Mix ($m), 2012 .............................................................. 160

13.2 Prosthetic Heart Valves Market, China, Segment Contribution (%), 2012 .................................................. 161

13.3 Prosthetic Heart Valves Market, China, Revenue ($m), by Segment, 2005-2012 ...................................... 162

13.4 Prosthetic Heart Valves Market, China, Revenue ($m) by Segment, 2012-2020 ....................................... 164

13.5 Prosthetic Heart Valves Market, China, Volume (Units) by Segment, 2005-2012 ...................................... 166

13.6 Prosthetic Heart Valves Market, China, Volume (Units) by Segment, 2012-2020 ...................................... 168

13.7 Prosthetic Heart Valves Market, China, Distribution Share, Revenue ($m), 2011-2012 ............................. 170

13.8 Prosthetic Heart Valves Market, China, Company Share by Revenue ($m), 2011-2012 ............................ 171

14 Overview of Key Companies in China, Cardiovascular Devices Market .................................................... 173

14.1 Medtronic, Inc. .............................................................................................................................................. 173

14.1.1 Company Overview .............................................................................................................................. 173

14.2 Lepu Medical Technology (Beijing) Co., Ltd. ............................................................................................... 173


14.3 Boston Scientific Corporation ....................................................................................................................... 173


14.4 Terumo Corporation ..................................................................................................................................... 174


14.5 St. Jude Medical, Inc. ................................................................................................................................... 174


14.6 Abbott Laboratories ...................................................................................................................................... 174


14.7 Biosensors International Group, Ltd............................................................................................................. 175




Page 5

14.8 Edwards Lifesciences Corporation............................................................................................................... 175


14.9 Cordis Corporation ....................................................................................................................................... 175


14.10 Asahi Intecc Co., Ltd. ............................................................................................................................... 176


14.11 Biotronik SE & Co. KG ............................................................................................................................. 176


14.12 Sorin S.p.A. .............................................................................................................................................. 176


14.13 Volcano Corporation................................................................................................................................. 176


14.14 Covidien plc .............................................................................................................................................. 177


14.15 Biosense Webster, Inc. ............................................................................................................................ 177


14.16 C. R. Bard, Inc. ......................................................................................................................................... 177


14.17 Lifetech Scientific (Shenzhen) Co., Ltd. ................................................................................................... 178


14.18 Philips Healthcare .................................................................................................................................... 178


14.19 Maquet Holding B.V. & Co. KG. ............................................................................................................... 178


15 Cardiovascular Devices Market Pipeline Products ...................................................................................... 179

16 Financial Deals Landscape ............................................................................................................................. 181

16.1 Acquisition .................................................................................................................................................... 181

16.1.1 Lepu Medical Technology To Acquire Additional 24.9% Stake In Shaanxi Qinming Medical Instruments 181

16.1.2 MicroPort Acquires D-Pulse Medical .................................................................................................... 183

16.1.3 MicroPort Scientific Acquires Winning Forward For US$5.3 Million .................................................... 184

16.1.4 Medtronic Completes Acquisition Of 26.4% Stake In LifeTech Scientific For US$66 Million .............. 185

16.1.5 MicroPort Medical Acquires Dongguan Kewei Medical From Savernake Investments For Up To US$17 Million 187

16.2 Asset Transactions ....................................................................................................................................... 189

16.2.1 AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million 189

16.3 Partnerships ................................................................................................................................................. 191

16.3.1 Vasomedical And PSK Enter Into Joint Venture Agreement To Form VSK Medical ........................... 191

16.3.2 Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology ................. 192

16.3.3 ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific ................................... 193

16.3.4 MicroPort Scientific To Form Joint Venture With Sorin ........................................................................ 194



Page 6

16.3.5 Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse .............................. 195

16.3.6 Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems 196

16.3.7 Micell Technologies Enters Into Co-Development Agreement With Hefei Life Science For MiStent SES 197

16.3.8 Coherex Medical Enters Into Distribution Agreement With Biosense Webster ................................... 198

16.3.9 Biosensors Enters Into Licensing Agreement With Eurocor ................................................................ 199

16.3.10 Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters .............. 201

16.3.11 TriReme Medical Enters Into Distribution Agreement With Weigao Medical Devices ......................... 202

16.3.12 Terumo Enters Into Agreement With Shanghai AngioCare Medical Technolgy .................................. 203

16.3.13 Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology .......................... 204

16.3.14 MicroPort Medical Forms Joint Venture With MicroPort Endovascular ............................................... 205

16.3.15 Boston Scientific Enters Into Agreement With Philips Healthcare ....................................................... 206

16.3.16 CardioComm Solutions Enters Into Co-Development Agreement With Monebo Technologies For ECG Interpretation Software .......................................................................................................................................... 207

17 Recent Developments ...................................................................................................................................... 209

17.1 Corporate Communications ......................................................................................................................... 209

17.1.1 Dec 19, 2013: Mindray Announced Shareholder Resolutions Post 2013 Annual General Meeting .... 209

17.1.2 Dec 16, 2013: Deutsche Private Equity Completes Acquisition Of Zellbios, API Manufacturer .......... 209

17.1.3 Dec 11, 2013: Appointment of Non-executive Director and Member of Nomination Committee......... 210

17.1.4 Nov 26, 2013: Mindray to Hold Annual General Meeting in Hong Kong on December 17, 2013 ........ 210

17.1.5 Jun 12, 2013: Mindray Medical Appoints Cheng Minghe As Co-CEO ................................................. 210

17.2 Financial Announcements ............................................................................................................................ 211

17.2.1 Mar 03, 2014: Mindray Announces 2013 Fourth Quarter and Full Year Results ................................. 211

17.2.2 Jan 13, 2014: Mindray Announces Preliminary 2013 Operating Results and 2014 Net Revenue Guidance 213

17.2.3 Dec 19, 2013: Withdrawal of NTCELL pre-clinical study ..................................................................... 214

17.2.4 Nov 04, 2013: Mindray Announces Third Quarter 2013 Financial Results .......................................... 215

17.2.5 Oct 15, 2013: Mindray to Report Third Quarter 2013 Financial Results on Nov. 4, 2013 ................... 217

17.2.6 Aug 05, 2013: Mindray Announces Second Quarter 2013 Financial Results ...................................... 217

17.2.7 Jul 16, 2013: Mindray to Report Second Quarter 2013 Financial Results on August 5, 2013 ............ 219

17.2.8 May 06, 2013: Mindray Reports Revenue Of $242.1m In Q1 2013 ..................................................... 219

17.2.9 May 05, 2013: Kindstar Global Exercises Option For Licensing Agreement With BioView For Lung Cancer Test ........................................................................................................................................................... 221

17.3 Government and Public Interest ................................................................................................................... 222

17.3.1 Apr 11, 2014: Oncolytics Biotech Collaborators Present Translational Brain Cancer Clinical Data and Immunomodulatory Preclinical Research at UK Oncolytic Virus Conference ....................................................... 222

17.3.2 Jan 02, 2014: Mindray to Participate in Upcoming Investor Conferences and Events ........................ 223

17.4 Legal And Regulatory ................................................................................................................................... 224

17.4.1 Nov 12, 2013: Mindray Announced a Settlement Agreement with Beckman Coulter ......................... 224

17.5 Other Significant Developments ................................................................................................................... 224

17.5.1 Mar 12, 2014: Compumedics gets boost in China with key $2.0m contracts ...................................... 224



Page 7

17.5.2 Mar 07, 2014: Mindray Announces ADS Dividend Record Date for March 2014 Dividend ................. 224

17.5.3 Jan 02, 2014: Response Biomedical Provides Update on Chinese Distribution Agreement with O&D Biotech 225

17.5.4 May 24, 2013: MicroPort Orthopedics Begins Construction At Suzhou Singapore Industrial Park, China 225

17.6 Product News ............................................................................................................................................... 225

17.6.1 Nov 27, 2013: MicroPort Received CE Approval for FireMagic, EasyFinder, EasyLoop and FireMagic 3D 225

17.6.2 Jul 01, 2013: Merit Medical Announces Multiple Regulatory Approvals .............................................. 226

18 Appendix ........................................................................................................................................................... 227

18.1 Research Methodology ................................................................................................................................ 228

18.1.1 Coverage .............................................................................................................................................. 228

18.1.2 Secondary Research ............................................................................................................................ 228

18.1.3 Primary Research ................................................................................................................................. 229

18.1.4 Market Modeling and Forecasting ........................................................................................................ 230

18.1.5 Company Share Analysis ..................................................................................................................... 233

18.1.6 Distribution Share Analysis .................................................................................................................. 234

18.2 Expert Panel ................................................................................................................................................. 234

18.3 GlobalData Consulting ................................................................................................................................. 235

18.4 Disclaimer ..................................................................................................................................................... 235



Page 8

1.1 List of Tables

Table 1: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, 2005-2020 ........................................................ 33

Table 2: Cardiovascular Devices Market, China, Category Contribution by Revenue ($m), 2012 .................................................. 36

Table 3: Cardiovascular Devices Market, China, Category Comparison by Revenue ($m), 2005-2020 ........................................ 38

Table 4: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 .......................................... 40

Table 5: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 ........................................ 42

Table 6: Cardiovascular Devices Market, China, Volume (Units), 2005-2020 ................................................................................ 44

Table 7: Cardiovascular Devices Market, China, Volume (Units), Historic, 2005-2012 .................................................................. 46

Table 8: Cardiovascular Devices Market, China, Volume (Units), Forecast, 2012-2020 ................................................................ 48

Table 9: Cardiovascular Devices Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012......................... 50

Table 10: Cardiac Assist Devices Market, China, Segment Contribution (%), 2012 ....................................................................... 52

Table 11: Cardiac Assist Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ......................................... 54

Table 12: Cardiac Assist Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ........................................ 56

Table 13: Cardiac Assist Devices Market, China, Volume (Units), Historic, 2005-2012 ................................................................. 58

Table 14: Cardiac Assist Devices Market, China, Volume (Units), Forecast, 2012-2020 ............................................................... 60

Table 15: Cardiac Assist Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ..................... 61

Table 16: Cardiac Assist Devices Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012........................ 63

Table 17: Cardiac Rhythm Management Market, China, Segment Contribution (%), 2012 ............................................................ 65

Table 18: Cardiac Rhythm Management Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 .............................. 67

Table 19: Cardiac Rhythm Management Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ............................. 69

Table 20: Cardiac Rhythm Management Market, China, Volume (Units), Historic, 2005-2012 ...................................................... 71

Table 21: Cardiac Rhythm Management Market, China, Volume (Units), Forecast, 2012-2020 .................................................... 73

Table 22: Cardiac Rhythm Management Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .......... 74

Table 23: Cardiac Rhythm Management Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 ............. 76

Table 24: Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012

......................................................................................................................................................................................................... 78

Table 25: Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020

......................................................................................................................................................................................................... 80

Table 26: Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), Historic, 2005-2012 ...................... 81

Table 27: Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), Forecast, 2012-2020 .................... 82

Table 28: Cardiovascular Monitoring and Diagnostic Devices Market, China, Distribution Share by Revenue ($m), USD Constant,

2011-2012 ........................................................................................................................................................................................ 83

Table 29: Cardiovascular Monitoring and Diagnostic Devices Market, China, Company Share by Revenue ($m), USD Constant,

2011-2012 ........................................................................................................................................................................................ 85

Table 30: Cardiovascular Prosthetic Devices Market, China, Segment Contribution (%), 2012 ..................................................... 87

Table 31: Cardiovascular Prosthetic Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ....................... 89

Table 32: Cardiovascular Prosthetic Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ...................... 91

Table 33: Cardiovascular Prosthetic Devices Market, China, Volume (Units), Historic, 2005-2012 ............................................... 93

Table 34: Cardiovascular Prosthetic Devices Market, China, Volume (Units), Forecast, 2012-2020 ............................................. 95

Table 35: Cardiovascular Prosthetic Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ... 96

Table 36: Cardiovascular Prosthetic Devices Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 ...... 98

Table 37: Cardiovascular Surgery Market, China, Segment Contribution (%), 2012 .................................................................... 100

Table 38: Cardiovascular Surgery Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ...................................... 102



Page 9

Table 39: Cardiovascular Surgery Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ..................................... 104

Table 40: Cardiovascular Surgery Market, China, Volume (Units), Historic, 2005-2012 .............................................................. 106

Table 41: Cardiovascular Surgery Market, China, Volume (Units), Forecast, 2012-2020 ............................................................ 108

Table 42: Cardiovascular Surgery Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .................. 109

Table 43: Cardiovascular Surgery Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 ..................... 111

Table 44: Electrophysiology Market, China, Segment Contribution (%), 2012 ............................................................................. 113

Table 45: Electrophysiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ................................................ 115

Table 46: Electrophysiology Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ............................................... 117

Table 47: Electrophysiology Market, China, Volume (Units), Historic, 2005-2012 ........................................................................ 119

Table 48: Electrophysiology Market, China, Volume (Units), Forecast, 2012-2020 ...................................................................... 121

Table 49: Electrophysiology Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012............................ 122

Table 50: Electrophysiology Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 .............................. 124

Table 51: External Defibrillators Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 .......................................... 125

Table 52: External Defibrillators Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ......................................... 126

Table 53: External Defibrillators Market, China, Volume (Units), Historic, 2005-2012 .................................................................. 127

Table 54: External Defibrillators Market, China, Volume (Units), Forecast, 2012-2020 ................................................................ 128

Table 55: External Defibrillators Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ...................... 129

Table 56: External Defibrillators Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 ........................ 131

Table 57: Interventional Cardiology Market, China, Segment Contribution (%), 2012 .................................................................. 134

Table 58: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 .................................... 136

Table 59: Interventional Cardiology Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ................................... 138

Table 60: Interventional Cardiology Market, China, Volume (Units), Historic, 2005-2012 ............................................................ 140

Table 61: Interventional Cardiology Market, China, Volume (Units), Forecast, 2012-2020 .......................................................... 142

Table 62: Interventional Cardiology Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ................ 143

Table 63: Interventional Cardiology Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 ................... 145

Table 64: Peripheral Vascular Devices Market, China, Segment Contribution (%), 2012 ............................................................ 148

Table 65: Peripheral Vascular Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ............................... 150

Table 66: Peripheral Vascular Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 .............................. 152

Table 67: Peripheral Vascular Devices Market, China, Volume (Units), Historic, 2005-2012 ....................................................... 154

Table 68: Peripheral Vascular Devices Market, China, Volume (Units), Forecast, 2012-2020 ..................................................... 156

Table 69: Peripheral Vascular Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ........... 157

Table 70: Peripheral Vascular Devices Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 ............. 159

Table 71: Prosthetic Heart Valves Market, China, Segment Contribution (%), 2012 .................................................................... 161

Table 72: Prosthetic Heart Valves Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ...................................... 163

Table 73: Prosthetic Heart Valves Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ..................................... 165

Table 74: Prosthetic Heart Valves Market, China, Volume (Units), Historic, 2005-2012 .............................................................. 167

Table 75: Prosthetic Heart Valves Market, China, Volume (Units), Forecast, 2012-2020 ............................................................ 169

Table 76: Prosthetic Heart Valves Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .................. 170

Table 77: Prosthetic Heart Valves Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 ..................... 172

Table 78: Cardiovascular Devices Market Pipeline Products ....................................................................................................... 179

Table 79: Lepu Medical Technology To Acquire Additional 24.9% Stake In Shaanxi Qinming Medical Instruments ................... 181

Table 80: MicroPort Acquires D-Pulse Medical ............................................................................................................................ 183

Table 81: MicroPort Scientific Acquires Winning Forward For US$5.3 Million .............................................................................. 184



Page 10

Table 82: Medtronic Completes Acquisition Of 26.4% Stake In LifeTech Scientific For US$66 Million ........................................ 185

Table 83: MicroPort Medical Acquires Dongguan Kewei Medical From Savernake Investments For Up To US$17 Million ......... 187

Table 84: AngioDynamics Completes Acquisition Of Rights To Microwave Ablation Technology For US$16 Million .................. 189

Table 85: Vasomedical And PSK Enter Into Joint Venture Agreement To Form VSK Medical .................................................... 191

Table 86: Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology ........................................... 192

Table 87: ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific ............................................................. 193

Table 88: MicroPort Scientific To Form Joint Venture With Sorin ................................................................................................. 194

Table 89: Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse ........................................................ 195

Table 90: Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems ...... 196

Table 91: Micell Technologies Enters Into Co-Development Agreement With Hefei Life Science For MiStent SES .................... 197

Table 92: Coherex Medical Enters Into Distribution Agreement With Biosense Webster ............................................................. 198

Table 93: Biosensors Enters Into Licensing Agreement With Eurocor ......................................................................................... 199

Table 94: Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters ........................................ 201

Table 95: TriReme Medical Enters Into Distribution Agreement With Weigao Medical Devices ................................................... 202

Table 96: Terumo Enters Into Agreement With Shanghai AngioCare Medical Technolgy ........................................................... 203

Table 97: Biosensors Extends Licensing Agreement With Terumo For BioMatrix Technology .................................................... 204

Table 98: MicroPort Medical Forms Joint Venture With MicroPort Endovascular ......................................................................... 205

Table 99: Boston Scientific Enters Into Agreement With Philips Healthcare ................................................................................ 206

Table 100: CardioComm Solutions Enters Into Co-Development Agreement With Monebo Technologies For ECG Interpretation

Software ......................................................................................................................................................................................... 207

Table 101: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country .................................. 230

1.2 List of Figures

Figure 1: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, 2005-2020 ....................................................... 32

Figure 2: Cardiovascular Devices Market, China, Revenue Mix ($m), 2012 .................................................................................. 34

Figure 3: Cardiovascular Devices Market, China, Category Contribution (%), 2012 ...................................................................... 35

Figure 4: Cardiovascular Devices Market, China, Category Comparison by Revenue ($m), 2005-2020 ....................................... 37

Figure 5: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ......................................... 39

Figure 6: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 ....................................... 41

Figure 7: Cardiovascular Devices Market, China, Volume (Units), 2005-2020 ............................................................................... 43

Figure 8: Cardiovascular Devices Market, China, Volume (Units), Historic, 2005-2012 ................................................................. 45

Figure 9: Cardiovascular Devices Market, China, Volume (Units), Forecast, 2012-2020 ............................................................... 47

Figure 10: Cardiovascular Devices Market, China, Company Share (%), 2012 ............................................................................. 49

Figure 11: Cardiac Assist Devices Market, China, Revenue Mix ($m), 2012 ................................................................................. 51

Figure 12: Cardiac Assist Devices Market, China, Segment Contribution (%), 2012 ..................................................................... 52

Figure 13: Cardiac Assist Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ........................................ 53

Figure 14: Cardiac Assist Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ....................................... 55

Figure 15: Cardiac Assist Devices Market, China, Volume (Units), Historic, 2005-2012 ................................................................ 57

Figure 16: Cardiac Assist Devices Market, China, Volume (Units), Forecast, 2012-2020 .............................................................. 59

Figure 17: Cardiac Assist Devices Market, China, Company Share (%), 2012 .............................................................................. 62

Figure 18: Cardiac Rhythm Management Market, China, Revenue Mix ($m), 2012 ...................................................................... 64

Figure 19: Cardiac Rhythm Management Market, China, Segment Contribution (%), 2012........................................................... 65

Figure 20: Cardiac Rhythm Management Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ............................. 66



Page 11

Figure 21: Cardiac Rhythm Management Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ............................ 68

Figure 22: Cardiac Rhythm Management Market, China, Volume (Units), Historic, 2005-2012 ..................................................... 70

Figure 23: Cardiac Rhythm Management Market, China, Volume (Units), Forecast, 2012-2020 ................................................... 72

Figure 24: Cardiac Rhythm Management Market, China, Company Share (%), 2012 ................................................................... 75

Figure 25: Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012

......................................................................................................................................................................................................... 77

Figure 26: Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020

......................................................................................................................................................................................................... 79

Figure 27: Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), Historic, 2005-2012 ..................... 81

Figure 28: Cardiovascular Monitoring and Diagnostic Devices Market, China, Volume (Units), Forecast, 2012-2020 ................... 82

Figure 29: Cardiovascular Monitoring and Diagnostic Devices Market, China, Company Share (%), 2012 ................................... 84

Figure 30: Cardiovascular Prosthetic Devices Market, China, Revenue Mix ($m), 2012 ............................................................... 86

Figure 31: Cardiovascular Prosthetic Devices Market, China, Segment Contribution (%), 2012 .................................................... 87

Figure 32: Cardiovascular Prosthetic Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ...................... 88

Figure 33: Cardiovascular Prosthetic Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ..................... 90

Figure 34: Cardiovascular Prosthetic Devices Market, China, Volume (Units), Historic, 2005-2012 .............................................. 92

Figure 35: Cardiovascular Prosthetic Devices Market, China, Volume (Units), Forecast, 2012-2020 ............................................ 94

Figure 36: Cardiovascular Prosthetic Devices Market, China, Company Share (%), 2012 ............................................................ 97

Figure 37: Cardiovascular Surgery Market, China, Revenue Mix ($m), 2012 ................................................................................. 99

Figure 38: Cardiovascular Surgery Market, China, Segment Contribution (%), 2012 ................................................................... 100

Figure 39: Cardiovascular Surgery Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ..................................... 101

Figure 40: Cardiovascular Surgery Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 .................................... 103

Figure 41: Cardiovascular Surgery Market, China, Volume (Units), Historic, 2005-2012 ............................................................. 105

Figure 42: Cardiovascular Surgery Market, China, Volume (Units), Forecast, 2012-2020 ........................................................... 107

Figure 43: Cardiovascular Surgery Market, China, Company Share (%), 2012 ........................................................................... 110

Figure 44: Electrophysiology Market, China, Revenue Mix ($m), 2012 ........................................................................................ 112

Figure 45: Electrophysiology Market, China, Segment Contribution (%), 2012 ............................................................................ 113

Figure 46: Electrophysiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ............................................... 114

Figure 47: Electrophysiology Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 .............................................. 116

Figure 48: Electrophysiology Market, China, Volume (Units), Historic, 2005-2012 ...................................................................... 118

Figure 49: Electrophysiology Market, China, Volume (Units), Forecast, 2012-2020 .................................................................... 120

Figure 50: Electrophysiology Market, China, Company Share (%), 2012 ..................................................................................... 123

Figure 51: External Defibrillators Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ......................................... 125

Figure 52: External Defibrillators Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ........................................ 126

Figure 53: External Defibrillators Market, China, Volume (Units), Historic, 2005-2012 ................................................................ 127

Figure 54: External Defibrillators Market, China, Volume (Units), Forecast, 2012-2020 .............................................................. 128

Figure 55: External Defibrillators Market, China, Company Share (%), 2012 ............................................................................... 130

Figure 56: Interventional Cardiology Market, China, Revenue Mix ($m), 2012 ............................................................................ 132

Figure 57: Interventional Cardiology Market, China, Segment Contribution (%), 2012 ................................................................ 133

Figure 58: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ................................... 135

Figure 59: Interventional Cardiology Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 .................................. 137

Figure 60: Interventional Cardiology Market, China, Volume (Units), Historic, 2005-2012 ........................................................... 139

Figure 61: Interventional Cardiology Market, China, Volume (Units), Forecast, 2012-2020 ......................................................... 141



Page 12

Figure 62: Interventional Cardiology Market, China, Company Share (%), 2012 ......................................................................... 144

Figure 63: Peripheral Vascular Devices Market, China, Revenue Mix ($m), 2012 ....................................................................... 146

Figure 64: Peripheral Vascular Devices Market, China, Segment Contribution (%), 2012 ........................................................... 147

Figure 65: Peripheral Vascular Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 .............................. 149

Figure 66: Peripheral Vascular Devices Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 ............................. 151

Figure 67: Peripheral Vascular Devices Market, China, Volume (Units), Historic, 2005-2012 ...................................................... 153

Figure 68: Peripheral Vascular Devices Market, China, Volume (Units), Forecast, 2012-2020 .................................................... 155

Figure 69: Peripheral Vascular Devices Market, China, Company Share (%), 2012 .................................................................... 158

Figure 70: Prosthetic Heart Valves Market, China, Revenue Mix ($m), 2012............................................................................... 160

Figure 71: Prosthetic Heart Valves Market, China, Segment Contribution (%), 2012 ................................................................... 161

Figure 72: Prosthetic Heart Valves Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 ..................................... 162

Figure 73: Prosthetic Heart Valves Market, China, Revenue ($m) USD Constant, Forecast, 2012-2020 .................................... 164

Figure 74: Prosthetic Heart Valves Market, China, Volume (Units), Historic, 2005-2012 ............................................................. 166

Figure 75: Prosthetic Heart Valves Market, China, Volume (Units), Forecast, 2012-2020 ........................................................... 168

Figure 76: Prosthetic Heart Valves Market, China, Company Share (%), 2012 ........................................................................... 171

Figure 77: GlobalData Epidemiology-Based Forecasting Model .................................................................................................. 232

Figure 78: GlobalData Capital Equipment-Based Forecasting Model .......................................................................................... 233

Figure 79: Primary Interviews by Participant Type (%) ................................................................................................................. 234



Page 13

2 Introduction

Medical Equipment Market Reports are the ideal guide for anyone wishing to understand their market better in terms

of revenues, unit sales, distributors and competitors.

2.1 What Is This Report About?

This report provides an overview and the following information related to the country, various categories, distribution

share and competitive landscape in the market:

1. Comprehensive data related to the market revenue, unit sale, company share and distribution share.

2. Corporate-level profiles of key companies operating in the Cardiovascular Devices market, which includes a

brief overview of the company. The selection of the companies is based on their operational presence.

3. A list of key products under development by different companies. The selection of this list is based on the

territory in which these products are being clinically investigated.

4. Key news and deals related to the Cardiovascular Devices market.

2.2 Cardiovascular Devices Market Segmentation

Cardiovascular Devices market is segmented into the following categories, as described below, in this report:

Cardiac Assist Devices includes segments such as

1. Total Artificial Heart

2. Intra-Aortic Balloon Pumps

Intra-Aortic Balloon Pumps includes sub-segments such as Intra-Aortic Balloon Pump Catheters and

Intra-Aortic Balloon Pump Consoles

3. Ventricular Assist Devices

Ventricular Assist Devices includes sub-segments such as Biventricular Assist Devices, External

Ventricular Assist Devices, Left Ventricular Assist Devices and Right Ventricular Assist Devices

Cardiac Rhythm Management Devices includes segments such as

1. Implantable Loop Recorders

2. Cardiac Resynchronisation Therapy

Cardiac Resynchronisation Therapy includes sub-segments such as Cardiac Resynchronisation

Therapy - Defibrillators and Cardiac Resynchronisation Therapy - Pacemakers

3. Implantable Cardioverter Defibrillators

Implantable Cardioverter Defibrillators includes Dual Chamber Implantable Cardioverter Defibrillators

and Single Chamber Implantable Cardioverter Defibrillators

4. Pacemakers

Pacemakers includes Dual Chamber Pacemakers and Single Chamber Pacemakers

Cardiovascular Monitoring and Diagnostic Devices includes segments such as

1. Cardiopulmonary Stress Testing Systems

2. ECG Data Management Systems

3. ECG Monitoring Equipment



Page 14

4. ECG Stress Testing Systems

5. Event Monitoring Systems

6. Holter Monitoring Systems

Cardiovascular Prosthetic Devices

1. Cardiac Valve Repairs

2. Septal Occluders

Septal Occluders includes sub-segments such as Atrial Septal Defect (ASD) Occluders, Patent

Foramen Ovale (PFO) Occluders and Ventricular Septal Defect (VSD) Occluders

Cardiovascular Surgery Devices includes segments such as

1. Cardiac Ablation Devices

2. Cardiopulmonary Bypass Equipment

3. Beating Heart Surgery Systems

Beating Heart Surgery Systems includes sub-segments such as Positioners and Stabilizers

4. Perfusion Disposables

Perfusion Disposables includes sub-segments such as Custom Tubing Packs and Oxygenators

Electrophysiology Devices includes segments such as

1. Electrophysiology Lab Systems

2. Electrophysiology Diagnostic Catheters

Electrophysiology Diagnostic Catheters includes sub-segments such as Standard Diagnostic

Catheters and Advanced Diagnostic Catheters

3. Electrophysiology Ablation Catheters

Electrophysiology Ablation Catheters includes sub-segments such as Standard Ablation Catheters

and Advanced Ablation Catheters

External Defibrillators includes segments such as

1. Manual Defibrillators

2. Professional AED

3. Public Access AED

Interventional Cardiology includes segments such as

1. PTCA Coronary Drug Eluting Balloons (DEB)

2. Coronary Guidewires

3. Arteriotomy Closure Devices

Arteriotomy Closure Devices includes sub-segments such as Femoral Access Devices and Radial

Access Devices

4. Cardiac Catheters

Cardiac Catheters includes sub-segments such as Angiography Catheters and Guiding Catheters

5. Coronary Stents

Coronary Stents includes sub-segments such as Bare Metal Stents and Drug Eluting Stents (DES)

6. Intravascular Ultrasound Systems (IVUS)

Intravascular Ultrasound Systems (IVUS) includes sub-segments such as Intravascular Ultrasound

Catheters and Intravascular Ultrasound System Consoles

7. PTCA Balloons



Page 15

PTCA Balloons includes sub-segments such as FW Balloons, Over the Wire Balloons, PTCA Cutting

and Scoring Balloons and Rx Balloons

Peripheral Vascular Devices includes segments such as

1. Renal Denervation Disposable Catheters

2. PTA Balloons

3. PTA Peripheral Drug Eluting Balloons (DEB)

4. Inferior Vena Cava Filters (IVCF)

Inferior Vena Cava Filters (IVCF) includes sub-segments such as Permanent IVCF and Retrievable

IVCF

5. Peripheral Embolic Protection Devices

Peripheral Embolic Protection Devices includes sub-segments such as Carotid Embolic Protection

Devices, Lower Extremity Embolic Protection Devices and Renal Embolic Protection Devices

6. Peripheral Guidewires

Peripheral Guidewires includes sub-segments such as Hydrophilic Peripheral Guidewires and Non-

Hydrophilic Peripheral Guidewires

7. Peripheral Vascular Stents

Peripheral Vascular Stents includes sub-segments such as Carotid Artery Bare Metal Stents, Fem-

pop Artery Stents (Fem-pop Artery Bare Metal Stents, Fem-pop Artery Bioabsorbable Stents, Fem-

pop Artery Covered Stents and Fem-pop Artery Drug Eluting Stents), Iliac Artery Stents (Iliac Artery

Bare Metal Stents, Iliac Artery Bioabsorbable Stents, Iliac Artery Covered Stents and Iliac Artery

Drug Eluting Stents), Infrapop Artery Stents (Infrapop Artery Bare Metal Stents, Infrapop Artery

Bioabsorbable Stents, Infrapop Artery Covered Stents and Infrapop Artery Drug Eluting Stents) and

Renal Artery Bare Metal Stents

8. Aortic Stent Grafts

Aortic Stent Grafts includes sub-segments such as Abdominal Aortic Stent Grafts and Thoracic

Aortic Stent Grafts

9. Vascular Grafts

10. Peripheral Venous Thrombectomy Devices

Peripheral Venous Thrombectomy Devices includes sub-segments such as Mechanical

Thrombectomy Devices and Aspiration Thrombectomy Devices

Prosthetic Heart Valves includes segments such as

1. Transcatheter Heart Valves

2. Mechanical Heart Valves

Mechanical Heart Valves includes sub-segments such as Mechanical Aortic Valve Replacements

and Mechanical Mitral Valve Replacements

3. Tissue Heart Valves

Tissue Heart Valves includes sub-segments such as Tissue Aortic Valve Replacements and Tissue

Mitral Valve Replacements



Page 16

2.3 Definitions of Markets Covered in the Report

Cardiac Assist Devices

Cardiac assist devices are used to support the failing heart which cannot be managed with standard medical therapy.

These devices can be used for both short term and long term purposes allowing the heart to rest long enough so that

it can return to normal. Cardiac assist devices include Total Artificial Heart (TAH) devices, Ventricular Assist Devices

(VAD) and Intra-Aortic Balloon Pumps (IABP).

Total Artificial Heart

A total artificial heart is a prosthetic device that is implanted into the body to replace the biological heart. One unit

refers to one total artificial heart.

Ventricular Assist Devices

A Ventricular Assist Device (VAD) is a mechanical pump that helps a heart that is too weak to pump blood through

the body. It is sometimes referred to as “a bridge to transplant” since it can help a patient survive until a heart

transplant can be performed.

Left Ventricular Assist Devices

A left ventricular assist device is a ventricular assist system intended for the treatment of advanced-stage heart failure. It assists the left ventricle in pumping the blood. One unit refers to one left ventricular assist device with accessories.

Right Ventricular Assist Devices

A right ventricular assist device is a ventricular assist system intended to assist the right ventricle in pumping the

blood. One unit refers to one right ventricular assist device with accessories.

External Ventricular Assist Devices

An external ventricular assist device is provided for augmenting cardiac contractions. This is connected surgically to

an EKG machine which actuates a fluid pump in response to the QRS waves of the heart. It consists of a flexible,

non-distensible shell adapted to be positioned over the heart base. One unit refers to one external ventricular assist

device with accessories.

Biventricular Assist Devices

Biventricular assist device is a ventricular assist system intended to assist both the ventricles in pumping the blood.

One unit refers to one biventricular assist device with accessories.

Intra-Aortic Balloon Pumps

The Intra-aortic Balloon Pump (IABP) is a mechanical device that is used to decrease myocardial oxygen demand

while at the same time increasing cardiac output. By increasing cardiac output it also increases coronary blood flow



Page 17

and therefore myocardial oxygen delivery. It consists of a cylindrical balloon that sits in the aorta and counter

pulsates.

Intra-Aortic Balloon Pump Catheters

Intra-Aortic Balloon Catheters are used in conjunction with Intra-Aortic Balloon Pumps to assist in improving the

cardiac output to meet the oxygen demand of the body. One unit refers to one Intra-Aortic Balloon Pump Catheter.

Intra-Aortic Balloon Pump Consoles

Intra-aortic balloon pump console triggers and optimizes counter pulsation support to patients. The console triggers

the counter pulsatisation based on factors like ECG readings or pressure required. These systems automatically sets

both the inflate and deflate timings. It comes along in a cart with a monitor and an internal battery. One unit refers to

one intra-aortic balloon pump console with all the above mentioned components.

Cardiac Rhythm Management

Cardiac Rhythm Management (CRM) devices are used to restore the natural synchronized pumping rhythm of the

heart. These include pacemakers, Cardiac Resynchronization Therapy (CRT), Implantable Loop Recorders and

Implantable Cardioverter Defibrillators (ICD). These Devices are used for the treatment of congestive heart failure.

Cardiac Resynchronisation Therapy

Cardiac Resynchronization Therapy (CRT) device is used for the treatment of heart failure-induced conduction

disturbances and ventricular dysynchrony. When used in combination with stable, optimal medical therapy, CRT is

designed to reduce symptoms and improve cardiac function by restoring the mechanical sequence of ventricular

activation and contraction.

Cardiac Resynchronisation Therapy – Defibrillators

Cardiac Resynchronisation Therapy – Defibrillator uses an Implantable Cardioverter Defibrillator (ICD) to improve the

coordination of the heart rhythm. This device utilizes three leads, one to the right atrium and one in each of the

ventricles. One unit refers to one cardiac resynchronisation therapy - defibrillator. Leads and electrodes are not

included here.

Cardiac Resynchronisation Therapy – Pacemakers

Cardiac Resynchronisation Therapy – Pacemaker uses a pacemaker device to improve the coordination of the heart

rhythm. This device utilizes three leads, one to the right atrium and one in each of the ventricles. One unit refers to

one cardiac resynchronisation therapy - pacemaker. Leads and electrodes are not included here.

Implantable Cardioverter Defibrillators

An Implantable Cardioverter Defibrillator (ICD) is a device which detects cardiac arrhythmia, or irregular beating of the

heart, and delivers a high voltage shock to restore the natural rhythm. This restores the natural rhythm of the heart.

The ICD is of the single chamber and dual chamber.



Page 18

Single Chamber Implantable Cardioverter Defibrillators

A single chamber Implantable Cardioverter Defibrillator (ICD) is a device which detects cardiac arrhythmia, or

irregular beating of the heart in one chamber (either an atrium or a ventricle) of the heart, and delivers a high voltage

shock to restore the natural rhythm. One unit refers to one single chamber implantable cardoverter defibrillator. Leads

and electrodes are not included here.

Dual Chamber Implantable Cardioverter Defibrillators

A dual chamber Implantable Cardioverter Defibrillator (ICD) is a device which detects cardiac arrhythmia, or irregular

beating of the heart in two chambers (the atrium or the ventricle) of the heart, and delivers a high voltage shock to

restore the natural rhythm. One unit refers to one dual chamber implantable cardioverter defibrillator. Leads and

electrodes are not included here.

Pacemakers

A pacemaker is a device designed to regulate the beating of the heart by providing electrical impulses delivered by

the electrodes contacting the heart muscle. It can be a single chamber or dual chamber type.

Dual Chamber Pacemakers

Dual chamber pacemakers have pacing leads in two chambers of the heart. One lead paces the atrium and one

paces the ventricle. This approach more closely matches the natural pacing of the heart. These types of pacemaker

can co-ordinate function between the atria and ventricles. Leads and electrodes are not included here. One unit refers

to one dual chamber pacemaker.

Single Chamber Pacemakers

A single chamber pacemaker is a device which has a single pacing lead placed into a chamber of the heart. This

could be the atrium or ventricle. Leads and electrodes are not included here. One unit refers to one single chamber

pacemaker.

Implantable Loop Recorder (ILR)

An Implantable Loop Recorder (ILR) is a subcutaneous, single-lead, electrocardiographic (ECG) monitoring device

used for diagnosis in patients with recurrent unexplained episodes of palpitations or syncope, along with long-term

monitoring in patients at risk for or with atrial fibrillation, structural heart disease, bundle branch block, recurrent

neurally mediated syncope etc. It consists of the insertable recorder that comes with a battery and two surface

electrodes. One unit refers to a single implantable loop recorder.

Cardiovascular Monitoring and Diagnostic Devices

Cardiovascular monitoring and diagnostic devices are used to detect and feedback abnormal episodes of electrical

functioning of the heart. The cardiovascular monitoring and diagnostic devices include Cardiopulmonary Stress



Page 19

Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems,

Event Monitoring Systems and Holter Monitoring Systems.

Cardiopulmonary Stress Testing Systems

Cardiopulmonary exercise or cardiopulmonary stress testing is done to non-invasively measure heart rate, cardiac

output, oxygen saturation, ventilation, and gas exchange to bring forth abnormalities not detectable at rest. The test is

used to characterize a patient's primary limitation of exercise tolerance as either cardiac or pulmonary in nature. In

addition, the test also provides an assessment of the response to a specific treatment regime. Physicians now

prescribe cardiopulmonary stress test for both cardiac and pulmonary function tests that help identify or assess

conditions of the heart and lungs. One unit refers to one cardio pulmonary stress testing system.

ECG Data Management Systems

ECG Database Management Systems are used to store and manage patients‟ ECG. It allows to capture and store

auditing information, report the serial ECG changes, and can communicate with other systems, such as hospital

information systems. Hospitals use ECG Data Management Systems to store and retrieve patients‟ ECG data. These

systems are integrated systems and are highly configurable to the individual hospital requirements. Multiple facilities

may share a single system. Only market for the main facility has been sized, not all facilities associated with the main

system. One unit refers to one new installation, upgrades are not considered while estimating the market size.

ECG Monitoring Equipment

Resting ECG equipment records the electrocardiogram (ECG) and is used to evaluate 10 seconds (or a specific time

interval) of electrical activity of the heart so a physician can determine the condition of a patient's heart. Resting ECG

equipment is primarily used for the 12-lead ECG test and is primarily used on a mobile cart or trolley. Resting ECG

equipment is NOT the same as ECG Bedside Patient Monitoring equipment. Single channel ECG machines are not

covered in this segment. One unit refers to one ECG monitoring equipment with more than 3 channels.

ECG Stress Testing Systems

ECG Stress Testing Systems or Tread Mill Testing (TMT) System is used to record ECG of the heart during

excessive workload. The system measures the performance of the heart at various stress levels. This does not

include cost of treadmill. One unit refers to one ECG recorder and PC based software.

Event Monitoring Systems

Event monitors or recorders are devices which record only the abnormal events of the ECG over an extended period

of time. One unit refers to one event monitor or recorder.

Holter Monitoring Systems

Holter monitoring systems record the ECG for a 24 or 48 hour period and are used to identify abnormal episodes of

the heart. The Holter system usually consists of a recorder, an interface circuit board, software for data analysis, and

an audio cassette or digital flash memory device for storage. One unit refers to one Holter monitoring system and a



Page 20

glenoid component made of this alloy or a combination of this alloy and ultra-high molecular weight polyethylene. One

unit is one implant set.

Cardiovascular Prosthetic Devices

Cardiovascular prosthetic devices are used to improve the survival and quality of life, treat chronic heart valve

conditions.

Cardiac Valve Repairs

Cardiac valve repair devices are used in the repair of malfunctioning valves. Only mitral valve repair has been

covered under this segment. Tricuspid and Aortic annuloplasty rings are not included here. One unit refers to one

annuloplasty cardiac valve repair ring.

Annuloplasty is a technique used to repair an enlarged annulus; a ring is placed at the base of the heart valve. This

annuloplasty ring makes the opening of valve smaller. The ring provides support to the valve so it can close more

tightly.

Septal Occluders

These devices are used to correct congenital heart defects. These defects generally include atrial septal defect,

ventricular septal defect, and the patent foramen ovale.

Atrial Septal Defect (ASD) Occluders

ASD occluder is used to close the abnormal hole in the wall of the upper chambers of the heart where the wall

between the right and left atria does not close completely. One unit refers to one ASD occluder.

Ventricular Septal Defect (VSD) Occluders

VSD occluder is used to close the defect in the ventricular septum. One unit refers to VSD occluder.

Patent Foramen Ovale (PFO) Occluders

PFO occluder is used to close the defect in the septum (wall) between the two upper (atrial) chambers of the heart.

One unit refers to one PFO Occluder.

Cardiovascular Surgery

This includes devices used in cardiovascular surgeries such as coronary artery bypass surgery. The category

includes devices and accessories used to aid in cardiovascular surgery.

Beating Heart Surgery Systems

Beating heart surgery systems are a new technique of cardiac surgery in which the heart continues to beat at its

normal rhythm during the surgery. This segment consists of positioners and stabilizers.



Page 21

Positioners

Positioners guide and hold the heart in a position that provides the best access to the blocked arteries. One unit

refers to one positioner.

Stabilizers

Stabilizers hold a small area of the heart still while a surgeon works on it. One unit refers to one stabilizer.

Cardiac Ablation Devices

Cardiac ablation devices are used to treat the atrial fibrillation by disrupting the abnormal pathways using

RF/Microwave energy or intense cold (cryoablation). Electrophysiology (EP) ablation is not tracked under this

segment. The system includes radiofrequency (RF) generator, remote control console and irrigation pump. One unit

refers to one cardiac ablation device consisting of the above mentioned devices.

Cardiopulmonary Bypass Equipment

Cardiopulmonary bypass equipment consists of the capital equipment used during cardio pulmonary bypass surgery.

This includes the heart-lung machine. One unit refers to one heart-lung machine.

Perfusion Disposables

Perfusion disposables consist of the disposable items used during cardio pulmonary bypass surgery. These include

custom packs and oxygenators. One oxygenator and one custom tubing pack are used for each on-pump procedure.

Custom Tubing Packs

Custom Tubing Packs are made from non-toxic medical grade P.V.C. tubing, and are used exclusively in combination

with heart lung machine and other devices of the system, such as oxygenator, blood cardioplegia delivery system.

The set is used exclusively for supply of blood & other liquids between the patient & extracorporeal system. A custom

tubing pack usually consists of tubing, connectors, fittings and monitoring cells. One unit refers to one custom tubing

pack.

Oxygenators

Oxygenators are devices in which blood and oxygen are separated by a semi-permeable membrane, generally of

Teflon or polypropylene, across which gas exchange occurs. These devices are used along with heart-lung machines

during cardiopulmonary bypass surgery. One unit refers to one oxygenator.

Electrophysiology

Electrophysiology equipment analyzes the electrical activity of the heart. The equipment is used with cardiac

catheters and sophisticated computers to generate electrocardiogram tracings and electrical measurements with



Page 22

exquisite precision from within the heart chambers. RF generators may be used in conjunction with electrophysiology

equipment to treat the abnormal impulse generating areas in the heart.

Electrophysiology Ablation Catheters

Electrophysiology ablation catheter is a catheter with an electrode on one end that emits mild radiofrequency energy

to destroy a small area of heart tissue in the abnormal pathway, preventing any further transmission of the impulses

causing the arrhythmia. Standard and advanced ablation catheters have been tracked under this segment.

Advanced Ablation Catheters

Advanced ablation catheters include irrigational tip catheters, cryo ablation catheters, laser ablation catheters and

navigational catheters. Navigational catheters are used in advance mapping devices which are not tracked under this

category. One unit is defined as one advanced ablation catheter.

Standard Ablation Catheters

Standard ablation catheter is a normal tip catheter (4mm-8mm) which is used in electrophysiology devices. One unit

is defined as one standard ablation catheter.

Electrophysiology Diagnostic Catheters

Electrophysiology diagnostic catheter is a tube with an electrode that is threaded through an artery into the heart

where it both records electrical activity and emits electrical impulses to test the heart‟s response. This test helps

doctors identify rhythm problems and pinpoint areas of the heart responsible for abnormal heart rates. One unit refers

to one electrophysiology diagnostic catheter. Standard and advanced diagnostic catheters have been tracked under

this segment.

Advanced Diagnostic Catheters

Advanced diagnostic catheters include pulmonary vein catheters (loop catheters). Ultrasound catheters are not

tracked under this category. One unit is defined as one advanced diagnostic catheter.

Standard Diagnostic Catheters

Standard diagnostic catheters include fixed and steerable diagnostic catheters. One unit is defined as one standard

diagnostic catheter.

Electrophysiology Lab Systems

Electrophysiology Lab Systems are used for the visualization, diagnosis and treatment of cardiac arrhythmias.

Electrophysiology lab systems include Advanced Mapping Systems, EP Recording Systems, X-ray Systems,

Intracardiac Echocardiography Systems, Radiofrequency Ablation Generators, EP Stimulators, Remote Navigation

Systems and Cryoablation Consoles. Only complete installations of Electrophysiology lab systems are tracked here.

One unit refers to one Electrophysiology lab system.



Page 23

External Defibrillators

External defibrillators are emergency medical devices that are predominantly used to diagnose life-threatening

abnormalities such as irregular heart rhythms (cardiac arrhythmia), and treat these conditions by delivering electrical

energy to the heart to restore its normal rhythm. These devices are used in emergency situations on the patients who

have suffered or collapsed due to sudden cardiac arrest. They are ideally used within a few minutes of the collapse.

Manual Defibrillators

Manual external defibrillators are used with an electrocardiogram display or have a built - in electrocardiogram to

diagnose the rhythm of the heart. On the basis of the diagnosis, the clinician then determines the energy amount to

be delivered to the patient. These devices are predominantly used in hospitals and in some ambulances with

doctors/physicians/skilled paramedics onboard.

Public Access AED

Public access AED's provide clear voice prompts that instruct users through the lifesaving cycle including prompts to

perform CPR, and step-by-step instructions on how to use the AED. It comes along with pads and connecting cables.

One unit refers to one public access AED defibrillator with a set of pads and connecting cables.

Professional AED

Professional AED's display the victim's heart rhythm on a built-in high resolution color ECG display and give

professional users the option of delivering defibrillation shocks either semi-automatically or manually during the

emergency treatment of a victim of sudden cardiac arrest. It comes along with pads and connecting cables. One unit

refers to one professional AED defibrillator with a set of pads and connecting cables.

Interventional Cardiology

Interventional cardiology includes devices used to diagnose and treat diseases related to the coronary artery using a

minimally invasive procedure. These include coronary stents, cardiac catheters, Percutaneous Transluminal Coronary

Angioplasty (PTCA) Balloons, coronary guidewires, Intravascular Ultrasound Systems (IVUS) and arteriotomy closure

devices. Electrophysiology products are not covered under this category.

Arteriotomy Closure Devices

Arteriotomy closure devices are used for carrying out hemostasis at the end of a percutaneous intervention (PCI).

This is used as an alternative to manual or mechanical compression. Radial access devices and femoral access

devices have been tracked under this segment.

Femoral Access Devices

Femoral closure devices are used for the percutaneous closure of common femoral artery access sites in patients

who have undergone diagnostic endovascular catheterization devices. Hemostasis is carried out by these devices

either by a clip, titanium staple or by an absorbable sealant. One unit refers to one femoral closure device.



Page 24

Radial Access Devices

Radial closure devices provide controlled compression of the radial artery without completely occluding vessel flow. It

consists of a transparent cuff, the air injection port, inflator and an adjustable band. One unit refers to one radial

closure device.

Cardiac Catheters

Cardiac catheters are narrow hollow tubes used for guiding and visualization of the coronary vasculature or the

functioning of heart valves. Cardiac catheters include guiding catheters and angiography catheters.

Angiography Catheters

Angiography catheters are used to administer a radio contrast dye into the chambers of the heart to detect any

abnormalities related to the coronary arteries or cardiac valves. One unit refers to one angiography catheter.

Guiding Catheters

Guiding catheters are catheters used to navigate stents, balloons and leads during a minimally invasive procedure.

One unit refers to one guiding catheter.

Coronary Stents

A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a

disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed

position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include

Bare Metal Stents (BMS) and Drug Eluting Stents (DES).

Bare Metal Stents

Bare metal stents (BMS) are uncoated stents that are permanently placed inside the artery. These stents are

constructed from a range of metals, including nitinol, stainless steel, and cobalt chromium. One unit refers to one bare

metal stent.

Drug Eluting Coronary Stents

Drug Eluting Stent (DES) is a BMS that releases drugs locally and can be coated with a polymeric material. The stent

releases an anti-proliferative or immunosuppressive drug over time, leaving behind the metallic stent in the artery.

One unit refers to one drug eluting stent.

Intravascular Ultrasound Systems

Intravascular ultrasound system is a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy and intravascular

ultrasound combined system intended to identify and characterize atherosclerotic plaque in the coronary arteries. It is

a combination device that uses IVUS to quantify the degree of narrowing produced by a plaque, the size of the artery

and the adequacy of stent expansion.



Page 25

Intravascular Ultrasound Catheters

Intravascular ultrasound catheter is an imaging catheter intended for evaluation of vascular morphology in blood

vessels of the coronary and peripheral vasculature. It provides cross-sectional image of such vessels. It incorporates

a cylindrical ultrasound transducer array used to radiate acoustic energy into the surrounding tissue and detects the

subsequent ultrasonic echoes. The information from the echoes is used to generate real-time images of the coronary

and peripheral vessels. One unit refers to one Intravascular Ultrasound Catheter.

Intravascular Ultrasound System Consoles

Intravascular Ultrasound System Console is the base unit which is integrated into the interventionalist lab with the

control panel, CPU, Color LCD Monitor, patient interface module for catheter designed to hang on bed rail. One unit

refers to one Intravascular Ultrasound System Consoles.

Percutaneous Transluminal Coronary Balloon (PTCA) Balloons

Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheters are used to restore blood flow in

occluded coronary arteries and deliver stents. PTCA balloons include Rapid Exchange (RX), Over-the-Wire, Fixed

Wire (FW) and Cutting and Scoring balloons.

Fixed Wire (FW) Balloon

A fixed wire angioplasty balloon catheter is an elongated, flexible, thin walled metal tube with an inflatable balloon on

the distal end. A FW PTCA catheter is used to compress plaque and dilate (widen) narrowed coronary arteries to

restore normal blood flow. This is often accompanied by implanting an expandable metal stent. One unit refers to one

FW balloon catheter.

Over the Wire Balloons

An over-the-wire balloon catheter consists of two lumens including one for the guidewire and the other for balloon

inflation. An over-the-wire PTCA catheter can be used compress plaque and dilate (widen) narrowed coronary

arteries to restore normal blood flow. This is often accompanied by implanting an expandable metal stent. One unit

refers to one over the wire balloon catheter.

PTCA Cutting and Scoring Balloons

Cutting and scoring balloon catheters have microsurgical blades mounted longitudinally on the angioplasty balloon

catheter. They can be advanced through occluded coronary arteries and used for plaque debulking. Cutting and

scoring balloon catheters exert less pressure compared with that by conventional balloon angioplasty catheters. One

unit refers to one PTCA cutting and scoring balloon catheter.

Rx Balloons

An Rx balloon catheter has an elongated shaft, two lumens for balloon inflation and guidewire and a proximal and

distal shaft. An angioplasty balloon is located on the distal shaft of the catheter. A Rx PTCA catheter is used to



Page 26

compress plaque and dilate (widen) narrowed coronary arteries to restore normal blood flow. One unit refers to one

Rx balloon catheter.

PTCA Drug Eluting Balloons (DEB)

A drug eluting balloon (DEB) is an anti-restenotic drug coated PTCA (Percuatneous Transluminal Coronary

Angioplasty) balloon intended to prevent re-narrowing of the coronary arteries. DEBs provide fast, short-term,

homogenous, local drug delivery, preserve the anatomy of the vessel, promote enhanced vessel healing, and reduce

the need for prolonged dual anti-platelet therapy without leaving any metal behind. They can be used for coronary

and peripheral artery applications including treating in-stent restenosis (ISR), bifurcations, small vessels, and long

lesions. One unit refers to one PTCA drug eluting balloon.

Peripheral Vascular Devices

Peripheral vascular devices include devices used to treat peripheral vascular disease (PVD). These include

peripheral vascular stents, peripheral non vascular stents, peripheral guidewires, percutaneous transluminal

angioplasty (PTA) balloons, grafts (allograft and artificial) and embolic protection devices.

Inferior Vena Cava Filter (IVCF)

Inferior Vena Cava Filter (IVCF) is used to prevent emboli from reaching lungs which results in Pulmonary Embolism

(PE). It includes Retrievable IVCF and Permanent IVCF.

Permanent IVCF

Permanent IVCF are the one's which cannot be removed or repositioned. One unit refers to one Permanent IVCF.

Retrievable IVCF

Temporary or retrievable IVCF are the one‟s which can be retrieved or repositioned up to a certain point of time. It

includes both temporary filters that must be retrieved and retrievable filters where retrieval is optional. One unit refers

to one Retrievable IVCF.

Peripheral Embolic Protection Devices

Peripheral Embolic Protection devices prevent the emboli or other debris from blocking and disrupting blood flow in

the body. Carotid, renal and lower extremity embolic protection devices have been tracked under this segment.

Carotid Embolic Protection Devices

Carotid embolic protection devices are used to prevent the debris from reaching the brain during carotid angioplasty.

One unit refers to one embolic protection device used in carotid angioplasty.



Page 27

Renal Embolic Protection Devices

Renal embolic protection devices are used to prevent the debris from reaching the kidney while placing a stent in the

renal artery. One unit refers to one renal embolic protection device.

Lower Extremity Embolic Protection Devices

Lower extremity embolic protection devices are used during lower extremity interventions. One unit refers to one

lower extremity embolic protection device.

Peripheral Guidewires

Peripheral Guidewires are used during the percutaneous transluminal angioplasty and angiography for guiding the

stents or catheters to the site of action in the peripheral vasculature. Hydrophilic and Non-hydrophilic peripheral

guidewires are tracked under this segment.

Hydrophilic Peripheral Guidewires

Hydrophilic peripheral guidewires are coated with hydrophilic coating which provides maximum lubricity and helps to

facilitate catheter navigation. One unit refers to one hydrophilic peripheral guidewire.

Non-Hydrophilic Peripheral Guidewires

Non-hydrophilic peripheral guidewires are peripheral guidewires which do not have a hydrophilic coating and may

include other coatings such as PTFE, silicone etc. One unit refers to one peripheral guidewire.

Peripheral Vascular Stents

Peripheral Vascular Stent is an expandable perforated tube that is inserted into a peripheral vessel to prevent blood

flow constriction. Carotid artery stents, Iliac Artery Stents, Infrapop Artery Stents, Renal Artery stents and Fem-pop

Artery stents, are covered under this segment.

Carotid Artery Bare Metal Stents

A carotid artery stent is the tube that is inserted in the Carotid artery, to increase the flow of blood blocked by plaque.

It is generally recommended for people who are unable to undergo an endarterectomy. Only Bare Metal Stents are

tracked under this sub-segment, as majority of the surgeries use Bare Metal Stents for Carotid Artery Stenting. One

unit refers to one Carotid Artery Bare Metal Stent.

Renal Artery Bare Metal Stents

Renal stent is a tube that is inserted in the renal arteries to increase blood flow to kidneys. Only Bare Metal Stents are

tracked under this sub-segment, as majority of the surgeries use Bare Metal Stents for the Renal Artery Stenting. One

unit refers to one Renal Artery Bare Metal Stent.



Page 28

Fem-pop Artery Stents

A Fem-pop Stent is a tiny, expandable metal coil that is inserted into the femoral and popliteal arteries located in thigh

and knee during the femoropopliteal artery stenting devices. Fem-pop Artery Stents are further segmented into;

Fem-pop Artery Bare Metal Stents

Fem-pop Artery Bare-metal stent is a stent without a coating. It is a mesh-like tube of thin wire. One unit refers to one

Fem-pop Artery Bare Metal Stent.

Fem-pop Artery Drug Eluting Stents

Fem-pop Artery Drug-Eluting stent is coated with a medicine or drug that helps further prevent the arteries from re-

closing. One unit refers to one Fem-pop Artery Drug Eluting Stent.

Fem-pop Artery Covered Stents

Fem-pop Artery Covered Stent is a flexible tube used to repair or support a damaged section of an artery. These

stents are made up of a metallic frame which is covered by durable fabric. One unit refers to one Fem-pop Artery

Covered Stent.

Fem-pop Artery Bio-absorbable Stents

Fem-pop Artery Bio-absorbable Stent is manufactured from a material that may dissolve or be absorbed in the body.

One unit refers to one Fem-pop Artery Bio-absorbable Stent.

Iliac Artery Stents

An Iliac artery stent is the tube that is inserted in the Iliac artery to increase the flow of blood in the narrowed iliac

arteries. Iliac Artery Stents are further segmented into;

Iliac Artery Bare Metal Stents

lliac Artery Bare-metal stent is a stent without a coating. It is a mesh-like tube of thin wire. One unit refers to one Iliac

Artery Bare Metal Stent.

Iliac Artery Drug Eluting Stents

liac Artery Drug-Eluting stent is coated with a medicine or drug that helps further prevent the arteries from re-

closing. One unit refers to one Iliac Artery Drug Eluting Stent.

Iliac Artery Covered Stents

Iliac Artery Covered Stent is a flexible tube used to repair or support a damaged section of an artery. These stents

are made up of a metallic frame which is covered by durable fabric. One unit refers to one Iliac Artery Covered Stent.



Page 29

Iliac Artery Bio-absorbable Stents

Iliac Artery Bio-absorbable Stent is manufactured from a material that may dissolve or be absorbed in the body. One

unit refers to one Iliac Artery Bio-absorbable Stent.

Infrapop Artery Stents

An Infrapop Stent is a tiny, expandable metal coil that is inserted to establish flow in the tibial, peroneal or pedal

arteries. Infrapop Artery Stents are further classified into;

Infrapop Artery Bare Metal Stents

Infrapop Artery Bare-metal stent is a stent without a coating. It is a mesh-like tube of thin wire. One unit refers to one

Infrapop Artery Bare Metal Stent.

Infrapop Artery Drug Eluting Stents

Infrapop Artery Drug-Eluting stent is coated with a medicine or drug that helps further prevent the arteries from re-

closing. One unit refers to one Infrapop Artery Drug Eluting Stent.

Infrapop Artery Covered Stents

Infrapop Artery Covered Stent is a flexible tube used to repair or support a damaged section of an artery. These

stents are made up of a metallic frame which is covered by durable fabric. One unit refers to one Infrapop Artery

Covered Stent.

Infrapop Artery Bio-absorbable Stents

Infrapop Artery Bio-absorbable Stent is manufactured from a material that may dissolve or be absorbed in the body.

One unit refers to one Infrapop Artery Bio-absorbable Stent.

Renal Denervation Disposable Catheters

Renal Denervation is a catheter based specialized ablation procedure used to reduce blood pressure in patients with

hypertension, or who are resistant to medical therapy. During this procedure, Radio Frequency (RF) energy is

delivered to the renal artery using a catheter with a RF energy electrode tip. This ablation delivered to the renal artery

disrupts the renal nerves resulting in reduction of blood pressure. One unit refers to one Renal Denervation

Disposable Catheter.

PTA Balloons

Percutaneous Transluminal Angioplasty (PTA) balloon catheters are used to compress plaque and dilate the arterial

wall to restore normal blood flow through the vessel. A PTA balloon catheter has a small folded balloon at the end of

the catheter. One unit refers to one PTA balloon catheter.



Page 30

PTA Peripheral Drug Eluting Balloons (DEB)

A Drug Eluting Balloon (DEB) is an anti-restenotic drug coated PTA (percutaneous transluminal angioplasty) balloon

intended to prevent re-narrowing of the peripheral arteries. DEBs provide fast, short-term, homogenous, local drug

delivery, preserve the anatomy of the vessel, promote enhanced vessel healing, and reduce the need for prolonged

dual antiplatelet therapy without leaving any metal behind. One unit refers to one PTA peripheral DEB.

Aortic Stent Grafts

Aortic Stent grafts are used to surgically reinforce a part of the diseased aorta such as blood filled dilation and are

used in cases that cannot be treated with intervention. It can be an allograft or a poly tetra fluro ethylene (PTFE) type.

These include thoracic aortic stent grafts and abdominal aortic stent grafts.

Abdominal Aortic Stent Grafts

Abdominal aortic stent grafts are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a

minimally invasive procedure. One unit refers to one abdominal stent graft.

Thoracic Aortic Stent Grafts

Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a

minimally invasive procedure. One unit refers to one thoracic aortic stent graft.

Vascular Grafts

Vascular grafts are used to repair or replace blood vessels in surgical devices. They are made up of Dacron or

polytetrafluroethylene (PTFE). It is also used to patch injured or diseased areas of arteries, for replacement of whole

segments of larger arteries such as the aorta. One unit refers to one vascular graft. In the taxonomy only synthetic

vascular grafts are tracked, thus preserved autologous grafts from other veins and arteries, cryo-preserved veins,

xenografts, arterial homograft are excluded from the analysis.

Peripheral Venous Thrombectomy Devices

Peripheral venous thrombectomy devices are the type of clot busting devices that are used to treat thrombus

containing lesions developed due to peripheral insufficiency. Mechanical Thrombectomy devices and Aspiration

Thrombectomy devices are tracked under this category:

Mechanical Thrombectomy Devices

Mechanical thrombectomy device involves the use of rotating coil which mechanically breaks the clot, sucking the

debris out through the catheter from the peripheral vasculature by negative pressure. One unit of mechanical

thrombectomy device consists of a catheter and a driving unit with a rotating coil to which the catheter is attached.

Aspiration Thrombectomy Devices

This type of thrombectomy device involves the application of negative pressure for the removal of thrombus from the

peripheral vasculature. The pressure is applied at the distal end of the catheter which leads to aspiration of the clot



Page 31

into the catheter. One unit of aspiration thrombectomy device consists of a catheter and a driving unit to which the

catheter is attached.

Prosthetic Heart Valves

Prosthetic heart valve is a device which mimics the function of human heart valves and have a passive mode of

functioning; opening and closing of valves are responses to pressure and flow changes within the heart. They are for

the patients that have a heart valvular disease where they need their valve to be replaced. Prosthetic heart valves

include both mechanical and tissue or biological heart valves.

Mechanical Heart Valves

Mechanical heart valves are generally made of non–physiological materials with a mobile occluder, which is made of

rigid materials.

Mechanical Aortic Valve Replacements

This includes replacement of the aortic heart valve using a mechanical prosthesis. One unit refers to one mechanical

aortic valve.

Mechanical Mitral Valve Replacements

This includes replacement of the mitral heart valve using a mechanical prosthesis. One unit refers to one mechanical mitral valve replacement.

Tissue Heart Valves

Tissue heart valve are a combination of tissue and synthetic biomaterials with the tissue itself being flexible. Bovine

and porcine valves are included here.

Tissue Aortic Valve Replacements

This includes replacement of the aortic heart valve using a biological prosthesis. One unit refers to one tissue aortic

valve.

Tissue Mitral Valve Replacements

This includes replacement of the mitral heart valve using a biological prosthesis. One unit refers to one tissue mitral

valve.

Transcatheter Heart Valves

The Transcathetar heart valve is a tissue valve replacement that can be compressed down to the diameter of a

pencil. It can be placed inside a beating heart using a catheter threaded through the patient's circulatory system or

through a small incision between ribs. Once inside the heart, the valve can then be opened into its natural position by

inflation of a balloon and deployed within the patient's diseased aortic valve. Only Aortic valve replacements are

tracked here. One unit refers to one Transcathetar heart valve.



Page 32

3 Cardiovascular Devices Market, China

3.1 Cardiovascular Devices Market, China, Revenue ($m), 2005-2020

Figure 1: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, 2005-2020

Source: GlobalData



Page 33

Table 1: Cardiovascular Devices Market, China, Revenue ($m), USD Constant, 2005-2020

Category 2005 2012 2020 CAGR 05-12 CAGR 12-20 CAGR 05-20

Source: GlobalData



Page 34

3.2 Cardiovascular Devices Market, China, Revenue Mix ($m), 2012

Figure 2: Cardiovascular Devices Market, China, Revenue Mix ($m), 2012

Source: GlobalData



Page 35

3.3 Cardiovascular Devices Market, China, Category Contribution by Revenue ($m), 2012

Figure 3: Cardiovascular Devices Market, China, Category Contribution (%), 2012

Source: GlobalData



Page 36

Table 2: Cardiovascular Devices Market, China, Category Contribution by Revenue ($m), 2012

Category Revenue ($m) Contribution Revenue (%) Contribution

Source: GlobalData



Page 227

18 Appendix

The data and analysis within this report are driven by Medical eTrack. Medical eTrack gives you the key information

required to drive sales, investment and deal-making activity in your business. It includes the following:

15,000+ data tables showing market size across more than 780 medical equipment segments and 15 countries,

from 2005 and forecast to 2020

6,000+ primary expert interviews, conducted annually to ensure data and report quality

1,100+ medical equipment conference reports

1,000+ industry-leading reports per annum, covering growing sectors, market trends, investment opportunities

and competitive landscape

600+ analysis reports, covering market and pipeline product analysis, by indication; medical equipment trends

and issues, and investment and M&A trends worth over $3m

50,000+ medical equipment company profiles

2,000+ private, emerging and technology start-up company profiles

4,000+ company profiles of medical equipment manufacturers in China and India

2,000+ company profiles of medical equipment manufacturers in Japan

825+ companies‟ revenue splits and market shares

1,100+ quarterly and annual medical equipment company financials

700+ medical equipment company SWOTs

11,700+ pipeline product profiles

14,000+ marketed product profiles

16,900+ clinical trials

17,000+ trial investigators

18,000+ new product patents

3,700+ reports on companies with products in development

21,500+ reports on deals in the medical equipment industry

1,300+ surgical and diagnostic procedures by therapy area

50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:

http://www.medicaletrack.com/ContactUs.aspx?Id=RequestDemo



Page 228

18.1 Research Methodology

GlobalData‟s dedicated research and analysis teams consist of experienced professionals with advanced statistical

expertise and marketing, market research and consulting backgrounds in the medical devices industry.

GlobalData adheres to the codes of practice of the European Pharmaceutical Marketing Research Association

(http://www.ephmra.org/).

All GlobalData databases are continuously updated and revised.

18.1.1 Coverage

The objective of updating GlobalData‟s coverage is to ensure that it represents the most up-to-date vision of the

industry possible.

Changes to the industry taxonomy are built on the basis of extensive research of company, association and

competitor sources.

Company coverage is based on three key factors: revenue; product and media attention; and innovation and market

potential.

The estimated revenue of all major companies, both private and public, are gathered and used to prioritize coverage.

GlobalData aims to cover all major news events and deals in the medical devices industry, updated on a daily basis.

The coverage is further streamlined and strengthened with additional input from GlobalData‟s expert panel.

18.1.2 Secondary Research

The research process begins with extensive secondary research using internal and external sources to gather all

relevant data and information pertaining to a particular market model for a particular country. The secondary research

sources that are typically referred to include, but are not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings

Industry trade journals, scientific journals and other technical literature

Association and healthcare organization websites

PubMed, Medscape and other relevant services which compile extensive reviews of clinical literature

Internal proprietary databases

Relevant patent and regulatory databases

National government documents, statistical databases and market reports

Procedure registries

News articles, press releases and web-casts specific to the companies operating in the market



Page 229

18.1.3 Primary Research

GlobalData conducts interviews with industry participants and commentators in order to validate its data and analysis.

A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape and

future outlook

Helps to validate and strengthen secondary research findings

Further develops the analysis team‟s expertise and market understanding

Primary research involves email correspondence, telephone interviews and face-to-face interviews for each market,

category, segment and sub-segment across a range of geographies.

The participants who typically take part in such a process include, but are not limited to:

o Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and

national sales managers

o Distributors, paramedics and representatives from hospital stores, laboratories and pharmacies

o Outside experts: investment bankers, valuation experts and research analysts that specialize in specific

medical equipment markets

o Key opinion leaders: physicians and surgeons that specialize in the therapeutic areas in which the

medical device is used

The market data was validated based on the inputs from 1,771 primary research participants. The primary research

participants included stakeholders from demand side such as the cardiovascular surgeons, as well as participants

from the supply side such as the marketing managers, sales managers and product managers of companies

manufacturing/marketing cardiovascular devices.



Page 230

Table 101: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

Country Total Number of Primary Research Participants

United States 136

United Kingdom 120

Germany 128

France 153

Italy 121

Spain 134

Brazil 128

China 79

India 173

Russia 89

Japan 88

Australia 122

Canada 111

Mexico 90

South Korea 99

Total 1,771

Source: GlobalData

18.1.4 Market Modeling and Forecasting

GlobalData uses an epidemiology-based treatment flow model and capital equipment-based model to estimate and

forecast market size.

Epidemiology-Based Market Model and Forecasting

The epidemiology-based forecasting model uses epidemiology data gathered from research publications and primary

interviews with physicians to establish the target patient population and treatment flow pattern for individual diseases

and therapies. The data covers prevalence, incidence, diseased population, diagnosed population, and treatment

population.

The market forecast begins with the general population, the size of which varies depending on the indication.

Prevalence is the percentage of the total population that suffers from a particular disease or condition.

Incidence is the number of new cases of a condition, symptom, death or injury that develop during a specific

time period, such as one year.

The diseased population is the population suffering from a particular disease or condition.

The diagnosed population is the population that has been diagnosed with a particular disease or condition,

expressed as a percentage of the prevalence population.



Page 231

The treatment population is the percentage of the population that has been diagnosed with a particular

disease or condition.

Device uptake is the percentage of the treatment population using a particular device, determined based on

the primary responses and the information available in secondary sources.

The epidemiology-based forecasting model for a medical device is used to:

Determine the patient segment using a particular device or procedure

Determine the frequency of usage of a particular device depending on the patient type, which further helps to

determine the absolute unit sales of a device in a year

The market for any medical device is directly proportional to the volume of units sold and the price per unit.

Market size = volumes of units sold X ASP (Average Selling Price)

The volume of units sold is calculated from the number of patients using or that has been implanted with the device.

Data on treatment rate, diagnosis and surgical treatment rate, if unavailable from research publications, is gathered

from interviews with physicians and used to estimate the patient volume for the disease under consideration.

The ASP of a device is mostly gathered from primary and secondary sources. ASP is the price at which a device is

available in a target country to an end-user. For capital equipment, the end-user is typically considered to be the

healthcare setting. For implants and consumables purchased by patients, the end-user is the patient.

Factors such as company share, reimbursement, company type (local/domestic or multinational) are taken into

consideration during ASP analysis, which uses the following sources:

Company websites

Annual reports/industry reports

Press releases



Page 232

Epidemiology-Based Forecasting Model

Capital Equipment-Based Market Model and Forecasting

The capital equipment-based forecasting model is based on the installed base, replacements and new sales of a

specific type of capital equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. The

installed base is calculated from the average number of units per facility. Sales for a particular year are arrived at by

calculating the number of replacement units and new units (additional and first-time purchases). Secondary sources

and interviews with supply-side participants and key opinion leaders from healthcare facilities are used to arrive at

installed base and unit sales for a particular year. The factors typically affecting the forecast growth rates are:

Growth in the number of healthcare facilities

Healthcare spending and government programs and initiatives

Migration from low-end equipment to high-end equipment

Growth in the diagnosed population and treatment population

Figure 77: GlobalData Epidemiology-Based Forecasting Model

Source: GlobalData



Page 233

Capital Equipment-Based Forecasting Model

18.1.5 Company Share Analysis

Company shares are calculated by analyzing a company‟s sales in a particular market. In the case of public

companies, annual reports and regulatory filings, investor presentations, earnings call transcripts and broker reports

are used to determine a company‟s revenue in a particular market and in a particular geography.

In the case of the private companies, company share data is gathered mostly from primary interviews and secondary

sources. Company share analysis is based on primary interviews with:

Supply side (manufacturers)

Procurement side

Distributors

Hospital purchasing groups

Demand side (surgeons/specialists)

Figure 78: GlobalData Capital Equipment-Based Forecasting Model

Source: GlobalData



Page 234

The benefits of this approach are:

High number of respondents to validate and from which to derive accurate company shares

Broad view from the supply, demand, and procurement side

Prevents biased opinions being reproduced

Demand-side interviews with key opinion leaders help to understand their preferences for the devices of

specific companies, strengthening company share estimates

Primary Interviews by Participant Type

Figure 79: Primary Interviews by Participant Type (%)

The final company share data is based on input from the supply side, the procurement side and the demand side, as

well as secondary sources. Please note that market share for companies that are included under the „Others‟

category is not tracked on an individual basis.

18.1.6 Distribution Share Analysis

Distribution share information is gathered using a combination of secondary and primary research. It is supported by

primary interviews because the availability of secondary data is limited in most cases.

18.2 Expert Panel

GlobalData uses a panel of experts to cross-verify its databases and forecasts.

GlobalData‟s expert panel comprises marketing managers, product specialists, international sales managers from

medical device companies, academics from research universities, key opinion leaders from hospitals, consultants

from venture capital funds and distributors/suppliers of medical equipment and supplies.

Historic data and forecasts are relayed to GlobalData‟s expert panel for feedback and adjusted accordingly.

50

25

25

Procurement side Supply side Demand side



Page 235

18.3 GlobalData Consulting

We hope that the data and analysis in this brief will help you to make informed and imaginative business decisions. If

you have further requirements, GlobalData‟s consulting team may be able to help you. GlobalData offers tailor-made

analytical and advisory services to drive your key strategic decisions.

18.4 Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,

electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher,

GlobalData.

Documents

China Cardiovascular Devices Market Outlook to 2020 · China Cardiovascular Devices Market Outlook to 2020 GDMEMC0039DB / Published May 2014 ... 4 Cardiac Assist Devices Market, China